ES2183341T3 - Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados. - Google Patents

Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados.

Info

Publication number
ES2183341T3
ES2183341T3 ES98913857T ES98913857T ES2183341T3 ES 2183341 T3 ES2183341 T3 ES 2183341T3 ES 98913857 T ES98913857 T ES 98913857T ES 98913857 T ES98913857 T ES 98913857T ES 2183341 T3 ES2183341 T3 ES 2183341T3
Authority
ES
Spain
Prior art keywords
cosmetic
dermatological use
hydroxylated steroids
skin
hydroxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98913857T
Other languages
English (en)
Inventor
Fernand Joseph Dray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitasterol Sarl
Original Assignee
Vitasterol Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitasterol Sarl filed Critical Vitasterol Sarl
Application granted granted Critical
Publication of ES2183341T3 publication Critical patent/ES2183341T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La invención se refiere a la utilización de un esteroide 7 - hidroxilado en una composición para prevenir o tratar las manifestaciones del envejecimiento cutáneo y/o los efectos de las radiaciones UV en la piel. La invención se refiere también a un procedimiento de tratamiento cosmético de las manifestaciones del envejecimiento cutáneo y/o de los efectos de las radiaciones UV sobre la piel.
ES98913857T 1997-03-10 1998-03-06 Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados. Expired - Lifetime ES2183341T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702811A FR2760362B1 (fr) 1997-03-10 1997-03-10 Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles

Publications (1)

Publication Number Publication Date
ES2183341T3 true ES2183341T3 (es) 2003-03-16

Family

ID=9504568

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98913857T Expired - Lifetime ES2183341T3 (es) 1997-03-10 1998-03-06 Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados.

Country Status (8)

Country Link
US (2) US6407084B2 (es)
EP (1) EP0973524B1 (es)
JP (1) JP2001515488A (es)
AU (1) AU6840298A (es)
DE (1) DE69807454T2 (es)
ES (1) ES2183341T3 (es)
FR (1) FR2760362B1 (es)
WO (1) WO1998040074A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0908183A1 (en) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin
AU1822600A (en) * 1998-11-19 2000-06-05 Mrs, Llc Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
FR2803514B1 (fr) * 1999-10-13 2004-05-21 Oreal Compostion, notamment cosmetique, renfermant un steroide et un filtre uv liposoluble
FR2799645B1 (fr) * 1999-10-13 2004-04-30 Oreal Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
FR2818149A1 (fr) * 2000-12-15 2002-06-21 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou 7-ceto dhea et au moins un inhibiteur de 5 alpha-reductase
FR2818148B1 (fr) * 2000-12-15 2005-06-24 Oreal Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
FR2818132B1 (fr) * 2000-12-15 2003-01-17 Oreal Utilisation de la 7-hydroxy dhea et/ou de la 7-ceto dhea pour traiter les desordres lies a une suractivite de la 5 alpha-reductase
FR2818135B1 (fr) 2000-12-15 2003-02-14 Oreal Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
FR2827762A1 (fr) * 2001-07-24 2003-01-31 Oreal Utilisation de steroides comme amincissants
FR2828100B1 (fr) * 2001-08-02 2004-09-24 Galderma Res & Dev Composition de type emulsion inverse contenant de la dhea et/ou ses precurseurs ou derives, et ses utilisations en cosmetique et en dermatologie
FR2831441B1 (fr) * 2001-10-25 2003-12-26 Oreal Utilisation cosmetique de derives de la dhea
FR2831440B1 (fr) * 2001-10-25 2003-12-26 Oreal Composition cosmetique, renfermant un derive de la dhea et un agent apaisant
US20020172647A1 (en) * 2002-03-06 2002-11-21 L'oreal Composition containing a steroid and a liposoluble UV filter
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US8697152B2 (en) 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
EP1963280B1 (en) 2005-12-22 2015-10-28 Newron Pharmaceuticals S.p.A. 2-phenylethylamino derivatives as calcium and/or sodium channel modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1076001B (it) * 1977-01-04 1985-04-22 Also Lab Di Dr P Sorbini & C S Composizione per il trattamento del cuoio capelluto e contro la caduta dei capelli
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
GB8417895D0 (en) * 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US5461042A (en) * 1988-12-30 1995-10-24 Loria; Roger M. Regulation of the immune system
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
CN1248916A (zh) * 1997-01-24 2000-03-29 加利福尼亚大学董事会 FXR、PPARα和LXRα激活剂恢复屏障功能、促进表皮分化和抑制增生的用途

Also Published As

Publication number Publication date
US20010041696A1 (en) 2001-11-15
EP0973524B1 (fr) 2002-08-28
WO1998040074A1 (fr) 1998-09-17
DE69807454T2 (de) 2003-04-17
FR2760362B1 (fr) 2000-08-11
US20020165214A1 (en) 2002-11-07
FR2760362A1 (fr) 1998-09-11
US6620803B2 (en) 2003-09-16
AU6840298A (en) 1998-09-29
US6407084B2 (en) 2002-06-18
DE69807454D1 (de) 2002-10-02
EP0973524A1 (fr) 2000-01-26
JP2001515488A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
ES2183341T3 (es) Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados.
ES2181376T3 (es) Composicion cosmetica y/o dermatologica que contiene acido salicilico o un derivado del acido salicilico y su utilizacion.
ES2123670T3 (es) Composicion cosmetica que contiene retinol.
ES2099643T3 (es) Composicion para uso topico que contiene un antioxidante y un extracto bacteriano.
BR9801355A (pt) Emulsão óleo-em-água composição cosmética de uso tópico utilização de uma emulsão processo de tratamento não terapéutico da pele e processo de preparação de uma emulsão
BR9708362A (pt) Utilização de uma quantidade eficaz de um extrato e processo de tratamento cosmético
BR9702541A (pt) Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético
AR005941A1 (es) Composicion cosmetica, su uso, y procedimiento de tratamiento cosmetico de substancias queratinicas tales como el cabello empleando dicha composicion
ES2178250T3 (es) Derivados de aminofenol y su utilizacionm en cosmetica.
ES2123922T3 (es) Utilizacion de un antagonista de substancia p en una composicion cosmetica y composicion obtenida.
ES2185050T3 (es) Utilizacion de la octoxiglicerina en una composicion cosmetica y/o dermatologica como agente activo para el tratamiento de la seborrea y/o del acne.
ES2124638T3 (es) Composicion cosmetica que comprende un polimero fijante y un almidon anfotero.
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
BR9707623A (pt) Composição cosmética processo de tratamento cosmético das matérias queratínicas e utilização da composição
ES2112603T3 (es) Composicion cosmetica a base de goma de guar y de silicona oxialquileno.
BR9602991A (pt) Composições cosméticas hidratantes e protetoras da pele contra as radiações ultravioleta e infravermelha
BR8101965A (pt) Agente filtrante solar para radiacoes ultravioletas;composicao cosmetica;processo para protecao da pele contra radiacoes ultravioletas;composicao para tratamento da pele e do cabelo
ES2167852T3 (es) Utilizacion de derivados oxamato como agentes despigmentantes.
AR003901A1 (es) Composicion para el tratamiento de las fibras queratinicas que comprende al menos un polimero fijante y al menos un compuesto de tipo ceramida yprocedimientos.
ES2161088T3 (es) Utilizacion de un extracto de sanguisorba officinalis para favorecer la pigmentacion de la piel y/o de los cabellos.
ES2161020T3 (es) Composicion cosmetica o dermatologica que comprenden un polimero filmogeno, procedimiento de maquillaje y de tratamiento no terapeutico.
ES2117768T3 (es) Composicion cosmetica que contiene en asociacion una superoxido dismutasa y un pigmento melanico.
ES2102284T5 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
ES2159697T3 (es) Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida.
MX9304117A (es) Agente cosmetico para el tratamiento de la piel, contra el envejecimiento provocado por los rayos ultravioleta y procedimiento para su obtencion.